PLX3397 (Pexidartinib)

Pexidartinib · Plexxikon

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PLX3397 (Pexidartinib), covering 2025-02-14 to 2025-02-14. Get the full timeline:

Most recent: Clinical Trial Update: CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors [Phase 1, Phase 2]

See pricing